IRIS
SILVESTRIS, Nicola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.537
NA - Nord America 3.613
AS - Asia 3.369
SA - Sud America 1.203
Continente sconosciuto - Info sul continente non disponibili 178
AF - Africa 145
OC - Oceania 4
Totale 13.049
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.435
RU - Federazione Russa 2.468
SG - Singapore 1.353
BR - Brasile 980
CN - Cina 653
IE - Irlanda 615
HK - Hong Kong 524
IT - Italia 463
SE - Svezia 362
VN - Vietnam 251
DE - Germania 151
BD - Bangladesh 115
FR - Francia 108
IN - India 104
AR - Argentina 89
GB - Regno Unito 72
MX - Messico 72
FI - Finlandia 68
ID - Indonesia 68
AT - Austria 64
IQ - Iraq 53
CA - Canada 51
NL - Olanda 42
EC - Ecuador 38
ZA - Sudafrica 32
TR - Turchia 29
MA - Marocco 28
UZ - Uzbekistan 26
JP - Giappone 23
PK - Pakistan 23
PL - Polonia 21
CO - Colombia 20
MY - Malesia 20
VE - Venezuela 20
ES - Italia 18
UA - Ucraina 16
SA - Arabia Saudita 15
TN - Tunisia 15
EG - Egitto 14
PY - Paraguay 14
CL - Cile 13
DZ - Algeria 13
JM - Giamaica 13
KE - Kenya 12
NP - Nepal 12
PE - Perù 12
PH - Filippine 12
AE - Emirati Arabi Uniti 11
CZ - Repubblica Ceca 11
UY - Uruguay 11
CR - Costa Rica 9
TH - Thailandia 9
EE - Estonia 8
IL - Israele 8
BO - Bolivia 6
ET - Etiopia 6
HN - Honduras 6
JO - Giordania 6
SN - Senegal 6
AL - Albania 5
AZ - Azerbaigian 5
CI - Costa d'Avorio 5
GT - Guatemala 5
PA - Panama 5
PS - Palestinian Territory 5
SC - Seychelles 5
AO - Angola 4
BE - Belgio 4
IR - Iran 4
LB - Libano 4
LK - Sri Lanka 4
LT - Lituania 4
NO - Norvegia 4
OM - Oman 4
SY - Repubblica araba siriana 4
AU - Australia 3
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
BY - Bielorussia 3
BZ - Belize 3
DO - Repubblica Dominicana 3
GR - Grecia 3
KG - Kirghizistan 3
LV - Lettonia 3
MK - Macedonia 3
PT - Portogallo 3
RO - Romania 3
SV - El Salvador 3
TW - Taiwan 3
AM - Armenia 2
BH - Bahrain 2
BN - Brunei Darussalam 2
GE - Georgia 2
HU - Ungheria 2
IS - Islanda 2
KH - Cambogia 2
KZ - Kazakistan 2
QA - Qatar 2
TT - Trinidad e Tobago 2
AG - Antigua e Barbuda 1
Totale 12.851
Salva come PNG Salva come JPEG
Città #
Moscow 751
Ashburn 670
Dublin 613
Hong Kong 522
Singapore 517
Nyköping 349
Princeton 268
Dallas 257
San Jose 207
Messina 159
Beijing 145
Los Angeles 107
Medford 107
Council Bluffs 95
Chandler 86
Santa Clara 80
Ho Chi Minh City 79
São Paulo 76
New York 67
Nuremberg 61
Lauterbourg 60
Hanoi 51
Jakarta 45
The Dalles 45
Redondo Beach 43
Buffalo 42
Vienna 38
Milan 35
Orem 34
Guangzhou 32
Rio de Janeiro 31
Frankfurt am Main 30
Pune 29
Rome 27
Munich 26
Tianjin 26
Lappeenranta 25
Mexico City 24
Tashkent 24
Atlanta 23
Helsinki 21
Tokyo 21
Brooklyn 20
Shenzhen 20
Turku 20
Amsterdam 19
Chennai 18
Baghdad 17
Chicago 17
Porto Alegre 17
Shanghai 17
Arezzo 16
Brasília 16
Quito 16
Johannesburg 15
London 15
Haiphong 14
Belo Horizonte 13
Campinas 13
Montreal 13
Zhengzhou 13
Bari 12
Denver 12
Dhaka 12
Nairobi 12
Biên Hòa 11
Boston 11
Catania 11
Düsseldorf 11
Miami 11
Paternò 11
San Francisco 11
Stockholm 11
Warsaw 11
Guayaquil 10
Rheinfelden 10
Salvador 10
Sorocaba 10
Bogotá 9
Cairo 9
Memphis 9
Montevideo 9
Phoenix 9
Pittsburgh 9
Poplar 9
Portsmouth 9
Bangkok 8
Boardman 8
Brno 8
Buenos Aires 8
Cuiabá 8
Curitiba 8
Lima 8
Maceió 8
Prineville 8
Seattle 8
Tunis 8
Bexley 7
Caracas 7
Erbil 7
Totale 6.625
Salva come PNG Salva come JPEG
Nome #
Corticosteroids in oncology: Use, overuse, indications, contraindications. An Italian Association of Medical Oncology (AIOM)/ Italian Association of Medical Diabetologists (AMD)/ Italian Society of Endocrinology (SIE)/ Italian Society of Pharmacology (SIF) multidisciplinary consensus position paper 274
Overexpression of nuclear NHERF1 in advanced colorectal cancer: association with hypoxic microenvironment and tumor invasive phenotype. 185
Immune checkpoint inhibitors and neurotoxicity: a focus on diagnosis and management for a multidisciplinary approach 163
Autophagic-Related Proteins in Brain Gliomas: Role, Mechanisms, and Targeting Agents 161
Cardiotoxicity Induced by Immune Checkpoint Inhibitors: What a Cardio-Oncology Team Should Know and Do 154
Crosstalk between ILC3s and Microbiota: Implications for Colon Cancer Development and Treatment with Immune Check Point Inhibitors 151
Safety profile of tyrosine kinase inhibitors used in non-small-cell lung cancer: An analysis from the Italian pharmacovigilance database 146
"Pure" hepatoid tumors of the pancreas harboring CTNNB1 somatic mutations: a new entity among solid pseudopapillary neoplasms 145
Potential predictive role of gut microbiota to immunotherapy in HCC patients: a brief review 143
Circulating biomarkers as predictors of response to immune checkpoint inhibitors in NSCLC: Are we on the right path? 143
Neuropsychiatric Adverse Events with Monoclonal Antibodies Approved for Multiple Myeloma: An Analysis from the FDA Adverse Event Reporting System 142
A Systematic Review on PD-1 Blockade and PD-1 Gene-Editing of CAR-T Cells for Glioma Therapy: From Deciphering to Personalized Medicine 140
A moonshot approach toward the management of cancer patients in the COVID-19 time: What have we learned and what could the Italian network of cancer centers (Alliance against Cancer, ACC) do after the pandemic wave? 133
Actors on the Scene: Immune Cells in the Myeloma Niche 132
A Novel Prognostic Tool in Western and Eastern Biliary Tract Cancer Patients Treated in First-line Setting: the ECSIPOT Index 126
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial 126
Management of Endocrine and Metabolic Toxicities of Immune-Checkpoint Inhibitors: From Clinical Studies to a Real-Life Scenario 123
Basics and frontiers on pancreatic cancer for radiation oncology: Target delineation, SBRT, SIB technique, MRgRT, particle therapy, immunotherapy and clinical guidelines 122
Comparison Study of the Safety Profile of Olaparib Versus Niraparib: Analysis of Real-World Data from EudraVigilance 114
Extrahepatic Distal Cholangiocarcinoma vs. Pancreatic Ductal Adenocarcinoma: Histology and Molecular Profiling for Differential Diagnosis and Treatment 112
Dihydropyrimidine Dehydrogenase Polymorphism c.2194G>A Screening Is a Useful Tool for Decreasing Gastrointestinal and Hematological Adverse Drug Reaction Risk in Fluoropyrimidine-Treated Patients 107
Challenges and pitfalls in the management of endocrine toxicities from immune checkpoint inhibitors: a case presentation of synchronous thyrotoxicosis and primary adrenal insufficiency in a melanoma patient 107
Rare histotypes of epithelial biliary tract tumors: A literature review 107
Neuropsychiatric adverse drug reactions with oral tyrosine kinase inhibitors in metastatic colorectal cancer: an analysis from the FDA Adverse Event Reporting System 106
Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals 104
Targeted therapies for KRAS-mutant non-small cell lung cancer: from preclinical studies to clinical development-a narrative review 104
From bench to bedside: highlights from the International Dialogue on Ovarian Cancer 99
Neuropsychiatric Adverse Drug Reactions with Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumors: An Analysis from the European Spontaneous Adverse Event Reporting System 99
Photodynamic therapy with zinc phthalocyanine enhances the anti-cancer effect of tamoxifen in breast cancer cell line: Promising combination treatment against triple-negative breast cancer? 98
A Systematic Review and Meta-Analysis on the Significance of TIGIT in Solid Cancers: Dual TIGIT/PD-1 Blockade to Overcome Immune-Resistance in Solid Cancers 95
The Italian Rare Biliary tract Cancer initiative (IRaBiCa): A multicentric observational study of Gruppo Oncologico dell’Italia Meridionale (GOIM) in collaboration with Gruppo Italiano Colangiocarcinoma (GICO) 95
A Systematic Review on the Therapeutic Potentiality of PD-L1-Inhibiting MicroRNAs for Triple-Negative Breast Cancer: Toward Single-Cell Sequencing-Guided Biomimetic Delivery 92
Antiangiogenic agents after first line and sorafenib plus chemoembolization: A systematic review 92
Immune Checkpoint Inhibitors and the Kidney: A Focus on Diagnosis and Management for Personalised Medicine 91
Laparoscopic vs. open mesorectal excision for rectal cancer: Are these approaches still comparable? A systematic review and meta-analysis 91
Moving the target on the optimal adjuvant strategy for resected pancreatic cancers: A systematic review with meta-analysis 91
A randomized phase III study of fractionated docetaxel, oxaliplatin, capecitabine (low-tox) vs epirubicin, oxaliplatin and capecitabine (eox) in patients with locally advanced unresectable or metastatic gastric cancer: the lega trial 90
Active treatment given in the last weeks of life: poor quality cancer care or justifiable behavior? 89
FOLFIRINOX after first-line gemcitabine-based chemotherapy in advanced pancreatic cancer: a retrospective comparison with FOLFOX and FOLFIRI schedules 89
A Promising Role of TGF-β Pathway in Response to Regorafenib in Metastatic Colorectal Cancer: A Case Report 88
A prognostic model in patients with advanced biliary tract cancer receiving first-line chemotherapy 87
A scoping review on the potentiality of PD-L1-inhibiting microRNAs in treating colorectal cancer: Toward single-cell sequencing-guided biocompatible-based delivery 87
A Systematic Review of the Tumor-Infiltrating CD8+ T-Cells/PD-L1 Axis in High-Grade Glial Tumors: Toward Personalized Immuno-Oncology 86
Clinical practice guidelines for diagnosis, treatment and follow-up of exocrine pancreatic ductal adenocarcinoma: Evidence evaluation and recommendations by the italian association of medical oncology (AIOM) 86
Association of NOS3 and ANGPT2 Gene Polymorphisms with Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib: Results of the Multicenter Prospective INNOVATE Study 86
Somatic BRCA Mutation in a Cholangiocarcinoma Patient for HBOC Syndrome Detection 85
The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 84
The molecular profiling of solid tumors by liquid biopsy: a position paper of the AIOM-SIAPEC-IAP-SIBioC-SIC-SIF Italian Scientific Societies 84
Biomarker phenotyping drives clinical management in axillary sentinel node: A retrospective study on women with primary breast cancer in 2002 84
Khorana score and thromboembolic risk in stage II–III colorectal cancer patients: a post hoc analysis from the adjuvant TOSCA trial 83
A phase I study of capecitabine in combination with vinorelbine in advanced breast cancer 83
[Paraneoplastic syndromes of the central nervous system] 82
Metabolic disorders and gastroenteropancreatic-neuroendocrine tumors (GEP-NETs): How do they influence each other? An Italian Association of Medical Oncology (AIOM)/ Italian Association of Medical Diabetologists (AMD)/ Italian Society of Endocrinology (SIE)/ Italian Society of Pharmacology (SIF) multidisciplinary consensus position paper 82
[Apoptosis or programmed cell death: regulatory and pathophysiological mechanisms]. FT Apoptosi, o morte cellulare programmata: meccanismi regolatori e fisiopatologia 82
STAT3 Silencing and TLR7/8 Pathway Activation Repolarize and Suppress Myeloid-Derived Suppressor Cells From Breast Cancer Patients 82
Genomic characterization of undifferentiated sarcomatoid carcinoma of the pancreas 81
Microfluidic-Assisted Preparation of Targeted pH-Responsive Polymeric Micelles Improves Gemcitabine Effectiveness in PDAC: In Vitro Insights 81
Expression and characterization of a novel recombinant cytotoxin II from Naja naja oxiana venom: A potential treatment for breast cancer 81
Combination of Ipilimumab and Nivolumab in Cancers: From Clinical Practice to Ongoing Clinical Trials 81
A scoping review on the significance of programmed death-ligand 1-inhibiting microRNAs in non-small cell lung treatment: A single-cell RNA sequencing-based study 80
The prognostic nutritional index predicts survival and response to first-line chemotherapy in advanced biliary cancer 80
Antineoplastic dosing in overweight and obese cancer patients: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper 78
Anti-angiogenesis and Immunotherapy: Novel Paradigms to Envision Tailored Approaches in Renal Cell-Carcinoma 78
[Indices of disease activity in systemic lupus erythematosus. Review of the literature] 78
PD-L1 silencing inhibits triple-negative breast cancer development and upregulates T-cell-induced pro-inflammatory cytokines 77
A Systematic Review to Clarify the Prognostic Values of CD44 and CD44+CD24- Phenotype in Triple-Negative Breast Cancer Patients: Lessons Learned and The Road Ahead 77
Bortezomib Treatment Modulates Autophagy in Multiple Myeloma 77
Renal Disorders with Oral Tyrosine Kinase Inhibitors in Metastatic Colorectal Cancer: An Analysis from the FDA Adverse Event Reporting System Database 76
Neutrophils, Crucial, or Harmful Immune Cells Involved in Coronavirus Infection: A Bioinformatics Study 76
The role of PNI to predict survival in advanced hepatocellular carcinoma treated with Sorafenib 75
Second-line treatments for Advanced Hepatocellular Carcinoma: A Systematic Review and Bayesian Network Meta-analysis 75
Fluropyrimidine single agent or doublet chemotherapy as second line treatment in advanced biliary tract cancer 75
Cardiovascular Safety Profile of BRAF and MEK Inhibitors in Melanoma: FAERS Data Through a Retrospective Disproportionality Analysis (2014–2023) 74
Hydroxy-propil-β-cyclodextrin inclusion complexes of two biphenylnicotinamide derivatives: Formulation and anti-proliferative activity evaluation in pancreatic cancer cell models 74
Immune Checkpoint Inhibitor-Related Myositis: From Biology to Bedside 74
MiR-144: A new possible therapeutic target and diagnostic/prognostic tool in cancers 73
[Common variable immunodeficiency]. FT Immunodeficienza comune variabile 73
Prediction and validation of GUCA2B as the hub-gene in colorectal cancer based on co-expression network analysis: In-silico and in-vivo study 73
mRNA-COVID19 Vaccination Can Be Considered Safe and Tolerable for Frail Patients 72
null 72
Exploiting systems biology to investigate the gene modules and drugs in ovarian cancer: A hypothesis based on the weighted gene co-expression network analysis 72
Incidence of patients with bone metastases at diagnosis of solid tumors in adults: a large population-based study 72
Vaccination for herpes zoster in patients with solid tumors: a position paper on the behalf of the Associazione Italiana di Oncologia Medica (AIOM) 69
Prognostic Role and Clinical Significance of Tumor-Infiltrating Lymphocyte (TIL) and Programmed Death Ligand 1 (PD-L1) Expression in Triple-Negative Breast Cancer (TNBC): A Systematic Review and Meta-Analysis Study 69
Unveiling cardiovascular and respiratory toxicities with monoclonal antibodies in multiple myeloma: disproportionality analysis from the FDA Adverse Event Reporting System 68
The latest findings of PD-1/PD-L1 inhibitor application in gynecologic cancers 68
Prognostic factors in 868 advanced gastric cancer patients treated with second-line chemotherapy in the real world 66
The combination effect of Prominin1 (CD133) suppression and Oxaliplatin treatment in colorectal cancer therapy 65
Current approaches for combination therapy of cancer: The role of immunogenic cell death 65
Polybrominated Diphenyl Ethers (PBDEs) and Human Health: Effects on Metabolism, Diabetes and Cancer 64
Predictors of thyroid adverse events during cancer immunotherapy: a real-life experience at a single center 64
Identification of early diagnostic biomarkers via WGCNA in gastric cancer 62
Diabetes management in cancer patients. An Italian Association of Medical Oncology, Italian Association of Medical Diabetologists, Italian Society of Diabetology, Italian Society of Endocrinology and Italian Society of Pharmacology multidisciplinary consensus position paper 62
Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples 61
Italian oncologists and vaccinations against infectious diseases: Results of a survey of the Italian Association of Medical Oncology 60
The importance of immune checkpoints in immune monitoring: A future paradigm shift in the treatment of cancer 60
Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE-2 Study 60
Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells 59
Varied functions of immune checkpoints during cancer metastasis 58
Immunotherapy of cancer in single-cell RNA sequencing era: A precision medicine perspective 58
Totale 9.325
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.080
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.080
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022388 0 0 0 0 0 0 0 0 8 0 0 380
2022/20231.548 307 183 131 7 28 93 32 45 663 9 13 37
2023/2024379 53 58 33 27 33 55 44 10 9 8 6 43
2024/20252.786 66 43 46 127 209 84 126 389 564 233 301 598
2025/20267.385 358 470 572 503 568 1.336 811 838 749 571 298 311
2026/2027563 382 181 0 0 0 0 0 0 0 0 0 0
Totale 13.049